Morningstar

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Business Wire

Global Contrast Injectors Market 2020-2024 | Evolving Opportunities with Bayer AG and Bracco Spa | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
Pharmabiz

US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System

Bayer, a global enterprise with core competencies in the life science fields of health care and nutrition, announced 510(k) clearance from the US Food and Drug Administration (FDA) for its MEDRAD ...
PharmiWeb

Bayer receives FDA clearance for expanded use of MEDRAD® Stellant FLEX CT Injection System in Contrast Enhanced Mammography (CEM)

INDIANOLA, Pa., Dec. 19, 2019 /PRNewswire/ -- Bayer announced today the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indication of its MEDRAD ® ...
Nasdaq

Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...